Last reviewed · How we verify
NCT04614935
Adherence and Outcomes in Functional Constipation With a Constipation Action Plan
NA trial testing Action Plan in Adherence, Medication in 38 participants. Completed in 1 March 2022.
31 December 2021
Quick facts
| Lead sponsor | University of Alabama at Birmingham |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 38 |
| Start date | 1 November 2020 |
| Primary completion | 31 December 2021 |
| Estimated completion | 1 March 2022 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Action Plan
Conditions studied
- Adherence, Medication — all drugs for Adherence, Medication →
- Functional Constipation — all drugs for Functional Constipation →
- Pediatric ALL — all drugs for Pediatric ALL →
- Survey, Family Life — all drugs for Survey, Family Life →
Sponsor
University of Alabama at Birmingham
Who can join
Adults 4 to 8, any sex, with Adherence, Medication or Functional Constipation. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
We will be assessing for improvement in reported symptoms as well as reported quality of life in pediatric patients with functional constipation using a constipation action plan and an adherence log.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04614935
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Action Plan
Trials testing the same drug.
- NCT03175250 — Translation of Basic Research in Cognitive Science to HIV Risk · NA · completed
Other recruiting trials for Adherence, Medication
Currently open trials in the same condition.
- NCT06759805 — Electronic Cardiac Rehabilitation (eCardiacRehab) Feasibility Study · NA · recruiting
- NCT05613010 — Leveraging Technology to Improve Medication Adherence in Youth With Kidney or Liver Transplant · NA · recruiting
- NCT06056037 — Making ART Work Among Brazilian Youth · NA · recruiting
- NCT05619601 — Gender Differences in Prevention Strategies and Therapeutic Adherence After Acute Myocardial Infarction · active not recruiting
- NCT05374109 — SYV: A Mental Health Intervention to Improve HIV Outcomes in Tanzanian Youth · NA · active not recruiting
Other University of Alabama at Birmingham trials
Trials by the same sponsor.
- NCT04922229 — Comparative Effectiveness in the Management of Irreversible Pulpitis · NA · not yet recruiting
- NCT05060380 — Feasibility of a Novel Resistance Exercise in Individuals With Osteoporosis · NA · withdrawn
- NCT04768777 — Behavioral Intervention for Physical Activity and Sexual Dysfunction in Multiple Sclerosis · NA · not yet recruiting
- NCT06320951 — VITAL-IMPACT: Improving Cardiometabolic Health in Black Individuals Through Therapeutic Augmentation of Cyclic Guanosine · Phase 2 · not yet recruiting
- NCT07564934 — Leveraging Extended Reality Exergaming and Telehealth to Improve Physical Activity and Health in Children With Disabilit · Phase 2 · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04614935 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Alabama at Birmingham
- Last refreshed: 15 April 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04614935.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing